A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3

TerminadoFase 3ClinicalTrials.gov

ID: NCT03556202Tipo: INTERVENTIONALInicio: 3 de sept de 2018Fin estimado: 7 de feb de 2022

Traducción no disponible, mostrando original

Resumen

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

Elegibilidad

Edad mínima: 18 YearsSexo: ALL

Criterios de inclusión

Participant must have completed the last visit of an eligible study period of originating study.
Participant must be willing to follow the birth control measures during and after study treatment if woman of childbearing potential.

Criterios de exclusión

Participant must not have an unstable or uncontrolled illness, including but not limited to a cerebro-cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematologic, or neurologic disease or abnormal lab results, that the study investigator thinks makes it unsafe or inappropriate for the participant to participate in this study.
Participant must not have stopped taking mirikizumab during a previous study or if the study investigator thinks restarting mirikizumab would create an unacceptable risk to the participant.

Intervenciones

drug

Mirikizumab

Administered SC

Ubicaciones

Dermatology

CABA, Buenos Aires, Argentina

Instituto de Neumonología Y Dermatología

Capital Federal, Buenos Aires, Argentina

Psoriahue

Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina

Buenos Aires Skin

Buenos Aires, Ciudad Autónoma de Buenos Aire, Argentina

Clinica Adventista Belgrano

CABA, Ciudad Autónoma de Buenos Aire, Argentina

Centro de Investigaciones Metabólicas (CINME)

Buenos Aires, Argentina

Halitus Instituto Médico

Ciudad Autonoma de Buenos Aire, Argentina

Parra Dermatología

Mendoza, Argentina

Patrocinadores

PrincipalEli Lilly and Company

Aviso: La información de este ensayo proviene de fuentes públicas y tiene carácter exclusivamente informativo. No constituye asesoramiento médico, regulatorio ni de ningún otro tipo. Las traducciones son automatizadas y no poseen validez oficial. Consultá siempre con un profesional de la salud. Ver Términos de Uso.

A Multicenter, Long-Term Extension to Evaluate the Long-t... | EligiMed